LIGHT/TNFSF14 as a New Biomarker of Bone Disease in Multiple Myeloma Patients Experiencing Therapeutic Regimens.
Brunetti G, Rizzi R, Storlino G, Bortolotti S, Colaianni G, Sanesi L, Lippo L, Faienza MF, Mestice A, Curci P, Specchia G, Grano M, Colucci S.
Brunetti G, et al. Among authors: specchia g.
Front Immunol. 2018 Oct 23;9:2459. doi: 10.3389/fimmu.2018.02459. eCollection 2018.
Front Immunol. 2018.
PMID: 30405638
Free PMC article.